目前的情况和糖尿病视网膜病变中血糖变异的综合管理
Bo Chen1, Chaozan Shen2, Bao Sun3,4
1Department of Pharmacy, The Central Hospital of Yongzhou, Yongzhou, China.
Journal of translational medicine
|July 29, 2024
概括
血糖变化 (GV) 或血糖波动越来越多地被认为是糖尿病视网膜病变 (DR) 的危险因素,这是视力丧失的主要原因. 了解 GV 的理解
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病视网膜病变 (DR) 是全球劳动年龄成人视力损失的主要原因.
- 导致糖尿病DR的因素尚未完全理解.
- 血糖变化 (GV),定义为血糖水平的波动,正在成为糖尿病相关并发症的重要风险因素.
研究的目的:
- 审查目前对血糖变异性在糖尿病视网膜病变中的作用的理解.
- 探索GV对DR病原体产生贡献的基础机制.
- 讨论改善DR管理的基于机制的治疗策略.
主要方法:
- 对目前关于血糖变异和糖尿病视网膜病变的研究进行文献综述.
- 对将GV与DR发展联系起来的拟议机制的分析.
- 针对DR中的GV治疗干预的证据综合.
主要成果:
- GV被认为是对DR发展易感性的关键因素.
- 正在阐明GV影响DR病变的具体机制.
- 针对GV的治疗策略显示出增强DR管理的前景.
结论:
- 血糖的变化在糖尿病视网膜病变的发展中起着至关重要的作用.
- 针对性治疗需要对GV机制进行进一步的研究.
- 解决GV对于改善DR的临床管理至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy
250
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
250
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Pathophysiology of Diabetes
913
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
913
Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229


